Why Aehr Test Systems Stock Is Skyrocketing Today

Aehr Test Systems shares jumped 16.6% intraday (up 158.1% YTD) following a March 31 press release announcing a new customer contract and ahead of fiscal Q3 results due tomorrow. Management previously guided to $25M–$30M in sales for the second half, a non‑GAAP loss per share of $0.05–$0.09, and suggested $60M–$80M in bookings in the second half. The rally is supported by broader tech bullishness linked to easing geopolitical tail risks (U.S./Iran) and investor positioning, but the large run-up raises downside risk if tomorrow’s results fall short.

Analysis

Aehr's move reads as a classic headline-driven re-rating layered on an operational story with lumpy conversion dynamics. Equipment OEMs in test and burn‑in sit on long lead times for precision thermal hardware and power subsystems, which makes booked orders sticky but also means revenue recognition and margin expansion can show up episodically over quarters rather than smoothly.

Second‑order winners include service/consumable providers and third‑party burn‑in houses that capture recurring revenue as customers ramp power‑device production; losers are low‑margin, high‑volume test vendors who cannot compete on throughput for high‑current burn‑in. Geopolitical or fab‑capex delays will compress demand quickly because OEM order books are front‑loaded, producing a volatility arbitrage between near‑term sentiment and multi‑quarter delivery timelines.

The immediate risk is an expectations gap: investors are pricing forward conviction into a narrow data point window, so an otherwise constructive multi‑quarter backlog that fails to meet quarter‑specific conversion math will trigger outsized downside. Conversely, if multiple customers ramp over 6–18 months, the name can re‑rate materially; trade sizing should therefore separate near‑term event risk (days–weeks) from structural demand (quarters–years).

Key Decisions for Investors

• Tactical bullish options (near‑term, defined risk): Buy a 4–6 week AEHR call debit spread sized to 1–2% of NAV to play upside from a positive follow‑through print; max loss = premium, target = 200–300% return if revenue/bookings surprise meaningfully higher.
• Event‑arbitrage (post‑print, IV‑decay): If implied vol for the next 2 weeks >2x its 60‑day median, sell a 2‑week straddle sized to 0.5–1% NAV with a protective call spread collar to cap blowups; expected payoff is collection of elevated premium, tail risk limited by the collar.
• Idiosyncratic pair (3–6 months): Establish a long AEHR position (3–4% NAV) only on a >15% pullback from today's levels, paired with a 50% notional short position in SMH to hedge beta; use a 25% hard stop on the long leg—target asymmetric 2.5x upside vs downside if structural ramps materialize.
• Portfolio protection (months): Buy a 3‑month AEHR put ~25–30% OTM sized to cover existing exposure (or 1% NAV if initiating new exposure) as insurance against a bookings‑to‑revenue disappointment; cost is limited to premium and preserves upside participation.